FDA Clearance Tracker · DEN080015
NUCLEUS-X PTV CATHETER
Last checked: Nov 20, 2026Latest source record: Jun 11, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Jun 11, 2012
De Novo granted
Time to decision
1,265 days
Received Dec 24, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Post-NSE
Device class
Class II
The decision
- FDA number
- DEN080015
- Device name
- NUCLEUS-X PTV CATHETER
- Applicant
- NuMED, Inc.
- Applicant location
- Hopkinton, NY
- Received
- Dec 24, 2008
- Decided
- Jun 11, 2012
- Decision
- De Novo granted
- Submission type
- Post-NSE
Device type
- Device type
- Balloon Aortic Valvuloplasty (OZT)
- Device class
- Class II
- Regulation
- 21 CFR 870.1255
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN080015
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for NuMED, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K213915 · Decided Jan 12, 2022 · 28 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal, Dual-Balloon (NVM) · Cardiology
K211910 · Decided Jul 19, 2021 · 28 days after receipt
Device type: Catheter, Septostomy (DXF) · Cardiology
K211134 · Decided May 27, 2021 · 41 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal, Dual-Balloon (NVM) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.